Showing results (121-130 of 3,878) with videos related to

Sort By:
Pageof 388
Thrombosis and Haemostasis|September 21, 2023
Neutrophil Extracellular Traps: Potential Prothrombotic State Markers and Therapeutic Targets for Atrial FibrillationXing Liu, Xinjian Li, Shenglin Xiong, et al.
Clinical Cardiology|October 26, 2020
Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trialZhiqiang Zhao, Yu Yang, Jianwei Wang, et al.
Cardiovascular Therapeutics|July 1, 2017
Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbitsChangle Liu, Ruimeng Liu, Huaying Fu, et al.
Cardiovascular Drugs and Therapy|February 4, 2014
Protective effects of aliskiren on atrial ionic remodeling in a canine model of rapid atrial pacingZhiqiang Zhao, Xinghua Wang, Jian Li, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 28, 2016
Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine modelZhiqiang Zhao, Yan Chen, Weimin Li, et al.
Frontiers in Pharmacology|March 11, 2022
Long-Term Cardiac Damage Associated With Abdominal Irradiation in MiceZhaojia Wang, Ziheng Jia, Zandong Zhou, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 19, 2019
Effects of nicorandil infusion on ECG parameters in patients with unstable angina pectoris and percutaneous coronary interventionWeiding Wang, Xu Zhang, Kangyin Chen, et al.
Cardiovascular Diabetology|November 30, 2019
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic ratsQingmiao Shao, Lei Meng, Sharen Lee, et al.
Frontiers in Physiology|December 28, 2020
Higher Incidence of Atrial Fibrillation in Left Ventricular-to-Right Atrial Shunt PatientsHongda Chou, Hongxia Chen, Juan Xie, et al.
Clinical and Experimental Pharmacology & Physiology|May 21, 2022
Angiotensin receptor-neprilysin inhibitor attenuates cardiac hypertrophy and improves diastolic dysfunction in a mouse model of heart failure with preserved ejection fractionYue Zhang, Meng Yuan, Ya Suo, et al.
Pageof 388